Table 1—

Characteristics of subjects before and after 3 months of chromium supplementation

Chromium
Placebo
Baseline3 monthsBaseline3 months
Waist circumference (cm)108.1 ± 21.5105.7 ± 19.4114.5 ± 16.0111.7 ± 14.1 (P = 0.052 vs. baseline)
BMI (kg/m2)34.1 ± 8.934.7 ± 5.634.5 ± 8.734.5 ± 5.2
Serum chromium (nmol/l)1.4 ± 1.35.2 ± 8.9*3.3 ± 4.54.4 ± 4.0
Fasting plasma glucose (mmol/l)5.5 ± 0.95.6 ± 0.85.8 ± 0.85.8 ± 0.8
1-h glucose (mmol/l)9.8 ± 2.610.0 ± 2.210.6 ± 2.210.6 ± 2.0
2-h glucose (mmol/l)8.2 ± 2.47.9 ± 2.58.5 ± 2.38.1 ± 2.0
AUC23.4 ± 5.323.5 ± 4.924.9 ± 4.124.2 ± 4.4
Fasting insulin (mIU/l)11.7 ± 7.119.3 ± 22.215.3 ± 9.814.5 ± 10.3
HOMA-IR2.95 ± 2.104.76 ± 5.023.89 ± 2.543.73 ± 2.92
Triacylglycerides (mmol/l)1.89 ± 0.631.94 ± 0.832.47 ± 0.982.31 ± 0.94
Total cholesterol (mmol/l)4.78 ± 0.775.22 ± 0.984.83 ± 0.675.37 ± 0.78*
  • Data are means ± 1 SD.

  • *

    * P < 0.05. AUC, area under the curve during the OGTT.